Summarised Group supplementary information

Summarised Group revenue segmental analysis

for the year ended 30 June 2019

	2019 R'million	Restated 2018 R'million	Change %
Commercial Pharmaceuticals by customer geography	33 084	32 190	3
Sub-Saharan Africa	7 986	7 987	0
Developed Europe	7 381	7 420	(1)
Australasia	4 048	3 890	4
Latin America	3 083	2 930	5
Developing Europe & CIS	2 516	2 693	(7)
China	2 872	2 415	19
Japan	2 124	1 931	10
Other Asia	1 343	1 298	3
MENA	1 056	978	8
USA & Canada	675	648	4
Manufacturing revenue by geography of manufacture
Manufacturing revenue – finished dose form	1 235	1 521	(19)
Australasia	372	360	3
Developed Europe	627	625	0
Sub-Saharan Africa	236	536	(56)
Manufacturing revenue – active pharmaceutical ingredients	4 553	4 603	(1)
Developed Europe	4 087	4 271	(4)
Sub-Saharan Africa	353	332	6
Other Asia	113	–	>100%

Total Manufacturing revenue	5 788	6 124	(5)
Total revenue	38 872	38 314	1
Summary of regions
Sub-Saharan Africa	8 575	8 855	(3)
Developed Europe	12 095	12 316	(2)
Australasia	4 420	4 250	4
Latin America	3 083	2 930	5
Developing Europe & CIS	2 516	2 693	(7)
China	2 872	2 415	19
Japan	2 124	1 931	10
Other Asia	1 456	1 298	12
MENA	1 056	978	8
USA & Canada	675	648	4
Total revenue	38 872	38 314	1

	Year ended 30 June 2019
	Anaesthetics Brands R'million	Thrombosis Brands R'million	Sterile Focus Brands R'million	Regional Brands R'million	Total R'million
By Customer Geography
Commercial Pharmaceuticals
Sub-Saharan Africa	111	8	119	7 867	7 986
Developed Europe	2 191	3 411	5 602	1 779	7 381
Australasia	663	22	685	3 363	4 048
Latin America	894	75	969	2 114	3 083
Developing Europe & CIS	283	1 868	2 151	365	2 516
China	1 976	869	2 845	27	2 872
Japan	1 332	32	1 364	760	2 124
Other Asia	675	167	842	501	1 343
MENA	237	118	355	701	1 056
USA & Canada	321	14	335	340	675
Total Commercial Pharmaceuticals	8 683	6 584	15 267	17 817	33 084

	Restated year ended 30 June 2018
	Anaesthetics Brands R'million	Thrombosis Brands R'million	Sterile Focus Brands R'million	Regional Brands R'million	Total R'million
By Customer Geography
Commercial Pharmaceuticals
Sub-Saharan Africa	143	8	151	7 836	7 987
Developed Europe	2 154	3 473	5 627	1 793	7 420
Australasia	713	21	734	3 156	3 890
Latin America	870	71	941	1 989	2 930
Developing Europe & CIS	397	1 876	2 273	420	2 693
China	1 779	616	2 395	20	2 415
Japan	1 213	48	1 261	670	1 931
Other Asia	658	151	809	489	1 298
MENA	207	159	366	612	978
USA & Canada	304	8	312	336	648
Total Commercial Pharmaceuticals	8 438	6 431	14 869	17 321	32 190

	% Change
	Anaesthetics Brands %	Thrombosis Brands %	Sterile Focus Brands %	Regional Brands %	Total %
By Customer Geography
Commercial Pharmaceuticals
Sub-Saharan Africa	(22)	0	(21)	0	0
Developed Europe	2	(2)	0	(1)	(1)
Australasia	(7)	5	(7)	7	4
Latin America	3	6	3	6	5
Developing Europe & CIS	(29)	0	(5)	(13)	(7)
China	11	41	19	35	19
Japan	10	(33)	8	13	10
Other Asia	3	11	4	2	3
MENA	14	(26)	(3)	15	8
USA & Canada	6	75	7	1	4
Total Commercial Pharmaceuticals	3	2	3	3	3